Clinical Trial Detail

NCT ID NCT01593228
Title Treatment Extension Study for Patients Who Have Previously Participated and Have Benefited From Iniparib in a Clinical Trial
Recruitment Completed
Gender both
Phase Phase III
Variant Requirements No
Sponsors Sanofi
Indications

Advanced Solid Tumor

Therapies

Carboplatin + Doxorubicin + Iniparib

Iniparib + Paclitaxel

Iniparib + Irinotecan

Iniparib + Topotecan

Carboplatin + Gemcitabine + Iniparib

Iniparib

Age Groups: adult

No variant requirements are available.